Quick Answer
BioRestorative Therapies, Inc. reported Operating Income of -$15.65 million for fiscal year 2025.
BioRestorative Therapies, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$15.65M | -35.4% |
| 2024 | -$11.56M | +24.1% |
| 2023 | -$15.22M | +19.8% |
| 2022 | -$18.97M | +27.9% |
| 2021 | -$26.31M | -855.9% |
| 2020 | -$2.75M | +67.4% |
| 2019 | -$8.43M | -10.3% |
| 2018 | -$7.65M | +8.7% |
| 2017 | -$8.37M | -7.6% |
| 2016 | -$7.79M | -8.6% |
| 2015 | -$7.17M | -45.7% |
| 2014 | -$4.92M | -3.6% |
| 2013 | -$4.75M | +14.7% |
| 2012 | -$5.57M | -56.9% |
| 2011 | -$3.55M | -71.6% |
| 2010 | -$2.07M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.71M | -62.2% | -12.2% |
| June 30, 2025 | -$3.31M | -33.9% | +31.2% |
| March 31, 2025 | -$4.81M | -17.0% | -110.2% |
| September 30, 2024 | -$2.29M | +26.3% | +7.4% |
| June 30, 2024 | -$2.47M | +20.8% | +39.9% |
| March 31, 2024 | -$4.11M | +28.9% | -32.4% |
| September 30, 2023 | -$3.10M | +32.7% | +0.4% |
| June 30, 2023 | -$3.12M | +32.7% | +46.1% |
- BioRestorative Therapies, Inc. showed a decrease of -35.4% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, BioRestorative Therapies, Inc.’s operating income has declined by 656.1% (from -$2.07 million to -$15.65 million).
- The most recent figure is from BioRestorative Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: